Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
104M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
39.9M
-
Shares change
-
+9.83M
-
Total reported value, excl. options
-
$584M
-
Value change
-
+$144M
-
Number of buys
-
49
-
Number of sells
-
-42
-
Price
-
$14.65
Significant Holders of BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) as of Q4 2023
114 filings reported holding BMEZ - BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value as of Q4 2023.
BlackRock Health Sciences Term Trust - Common Shares, $0.001 par value (BMEZ) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.9M shares
of 104M outstanding shares and own 38.37% of the company stock.
Largest 10 shareholders include Saba Capital Management, L.P. (16.8M shares), MORGAN STANLEY (3.83M shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (1.97M shares), 1607 Capital Partners, LLC (1.56M shares), BANK OF AMERICA CORP /DE/ (1.55M shares), Invesco Ltd. (1.35M shares), UBS Group AG (1.35M shares), Almitas Capital LLC (1.29M shares), Karpus Management, Inc. (1.22M shares), and WELLS FARGO & COMPANY/MN (803K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.